Molecular “status” overcomes treatment strategy…
Favourable
Unfavourable
IDH1 mutated
IDH1 wt
1p/19q codeleted
1p/19q NON codeleted
RTOG 9402
Cairncross JG. et al. JCO 2014;32
EORTC 26951
Van den Bent MJ. et al. JCO 2013;31
…can we consider RT + PCV as standard of care ?




